Joshua M Eizen An2 Therapeutics, Inc. (ANTX) insider trading activity

ANTX Quotes by TradingView

Joshua M Eizen is of AN2 Therapeutics, Inc.. Currently has a direct ownership of 175,172 shares of ANTX, which is worth approximately $229,475. The most recent transaction as insider was on Feb 26, 2025, when has been sold 58,500 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 175K
38.66% 3M change
n/a 12M change
Total Value Held $229,475

Joshua M Eizen Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 26 2025
BUY
Grant, award, or other acquisition
-
58,500 Added 25.04%
175,172 Common Stock
Jan 03 2025
SELL
Open market or private sale
$12,948 $1.34 p/Share
9,663 Reduced 7.65%
116,672 Common Stock
Nov 04 2024
BUY
Grant, award, or other acquisition
-
31,500 Added 19.96%
126,335 Common Stock
Jul 10 2024
BUY
Grant, award, or other acquisition
-
60,000 Added 38.75%
94,833 Common Stock
Mar 15 2024
BUY
Grant, award, or other acquisition
-
30,000 Added 48.04%
32,447 Common Stock
JME

Joshua M Eizen

Menlo Park, CA

Track Institutional and Insider Activities on ANTX

Follow AN2 Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ANTX shares.

Notify only if

Insider Trading

Get notified when an An2 Therapeutics, Inc. insider buys or sells ANTX shares.

Notify only if

News

Receive news related to AN2 Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ANTX